Oxford BioMedica
	Developer of gene-based medicines and therapeutic vaccines. The company\'s technology platform includes a gene delivery system for the treatment of the diseases of the central nervous system and the eye and a tumor antigen for anti-cancer therapy.
	['', 'gene-based medicines', ' ', 'therapeutic vaccines', ' ', 'gene delivery system', ' ', 'tumor antigen', ' ', 'anti-cancer therapy', '']
Molecular Engines Laboratories
	Developer of a new generation of drugs against cancer. The company\'s research is focused on the analysis and understanding of the molecular mechanism which makes it possible for a cancer cell to quit its malignant state and to revert to a suppressed-malignant phenotype.
	['', 'cancer drug', ' ', 'cancer cell analysis', ' ', 'cancer research', '']
ACT Biotech
	Developer of cancer drugs. The company is focused on the development and commercialization of targeted oral and cancer drugs.
	['', 'oral cancer', ' ', 'cancer treatment', '']
JSK Therapeutics
	Developer of novel anti-cancer drugs using an approved compound to inhibit the growth of cancer cells. The company\'s business is based on two types of drugs, the first class of drug, has been tested in animal systems and the second class of drugs is not as developed as a cancer drug but is more versatile with wider range of cancers.
	['', 'cancer therapy', '']
Gloucester Pharmaceuticals
	Developer of cancer therapeutics. The company develops romidepsin, a histone deacetylase inhibitor and oncology drug candidate for T-cell lymphomas, as well as for the treatment of hematologic malignancies. It also develops treatments for hematological cancers, including cutaneous T-cell lymphoma, peripheral T-cell lymphoma, and multiple myeloma.
	['', 'cancer therapy', ' ', 'hematological cancer treatment', ' ', 'cancer drug', '']
Cancer Genetics
	Developer of personalized medicines for cancer diagnostics as well as treatments that are tailored to the specific genetic profile of the individual. The company provides cancer patient management to diagnose, monitor and inform treatment of cancer.
	['', 'cancer diagnostic', ' ', 'cancer treatment', ' ', 'cancer patient management', '']
Hémax Génome
	Provider of a gene-discovery platform for mapping a gene on the X chromosome that is involved in regulating hematopoiesis. The company also applies its gene-discovery platform to other genes responsible for diseases showing an unequal distribution amongst genders.
	['', 'gene-discovery platform', ' ', 'hematopoiesis regulation', ' ', 'genes identification', ' biotechnology']
Pathway Therapeutics
	Developer of therapeutics against human diseases. The company offers PI3 kinase, an enzyme identified as active in cancer tumor development.
	['', 'drug development', ' ', 'cancer treatment', ' ', 'lifesciences and oncology', '']
ZGene
	Provider of gene therapeutics for the treatment of cancer diseases. The company develops treatments for several cancer forms with an enzyme based gene suicide system that increase the activation of anti-cancer drugs in tumour cells with faster cell death.
	['', 'cancer treatment', ' ', 'gene suicide', ' ', 'anti-cancer drugs', '']
Tacere Therapeutics
	Developer of therapeutics for the treatment of serious infectious diseases such as Hepatitis C (HCV). The company utilizes gene silencing technology called DNA-directed RNA interference (ddRNAi).
	['', 'Hepatitis C', ' ', 'RNAi therapeutic', ' ', 'RNA interference drug', '']
